Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / COM
-
Number of holders
-
3001
-
Total 13F shares, excl. options
-
1.34B
-
Shares change
-
+60.2M
-
Total reported value, excl. options
-
$152B
-
Value change
-
+$6.81B
-
Put/Call ratio
-
0.78
-
Number of buys
-
1206
-
Number of sells
-
-1258
-
Price
-
$113.11
Significant Holders of ABBOTT LABORATORIES - COM (ABT) as of Q4 2024
3,203 filings reported holding ABT - ABBOTT LABORATORIES - COM as of Q4 2024.
ABBOTT LABORATORIES - COM (ABT) has 3,001 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.34B shares
.
Largest 10 shareholders include VANGUARD GROUP INC (169M shares), BlackRock, Inc. (137M shares), STATE STREET CORP (77.2M shares), Capital International Investors (68M shares), Capital Research Global Investors (54.1M shares), MORGAN STANLEY (36.1M shares), GEODE CAPITAL MANAGEMENT, LLC (35.7M shares), JPMORGAN CHASE & CO (35.2M shares), WELLINGTON MANAGEMENT GROUP LLP (26.4M shares), and NORTHERN TRUST CORP (22.1M shares).
This table shows the top 3001 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.